InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,180.74
(
1.03%
)
US TECH 100
17,610.00
(
0.00%
)
Dow Jones
38,852.27
(
0.46%
)
Brent Oil
83.04
(
-0.53%
)
Bitcoin
63,705.02
(
0.85%
)
Post# of 30046
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

GetSeriousOK

Send PM Follow Ignore
Followers 37
Posts 6862
Boards Moderated 1
Alias Born 09/06/2014

GetSeriousOK

Re: None

Saturday, 04/30/2016 7:14:59 PM

Saturday, April 30, 2016 7:14:59 PM

Post# of 30046
The questions that ONE holder of Radient wants answered:

- What real control does RXPC/ AMDL Diagnostics have over the use of Onko-Sure other than trademark of same?

Answer: no control whatsoever. Reason: no patents. (And regarding the Trademarks: AMDL Diagnostics owns those now, and "holders of Radient" don't own AMDL stock.)

- What benefit will current holders of Radient see when various companies proceed with going public and use Onko-Sure/ DR -70 as a cornerstone of their product development?

Answer: zero benefit. For too many reasons to list them all -- but the main reason is the lack of patent protection.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up